Kelyniam Wins FDA Clearance for First Fusion™ BCP-PEEK Implant
CANTON, Conn., September 18, 2025 – Kelyniam Global, Inc., a leader in custom cranial and craniofacial implant solutions, announced...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
CANTON, Conn., September 18, 2025 – Kelyniam Global, Inc., a leader in custom cranial and craniofacial implant solutions, announced...
DALLAS, Texas, September 12, 2025 — Ronovo Surgical has announced the launch of its latest line of advanced surgical...
MALVERN, Pennsylvania, September 10, 2025 — Elutia has announced the sale of its BioEnvelope business to Boston Scientific Corporation...
AliveDx, a global in-vitro diagnostics innovator, today announced it has submitted a 510(k) premarket notification to the U.S. Food...
